Quick Answer
Alto Neuroscience, Inc. reported Total Assets of $184.69 million for fiscal year 2025.
Alto Neuroscience, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $184.69M | +4.0% |
| 2024 | $177.54M | +104.9% |
| 2023 | $86.63M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $147.01M | -23.3% | -6.9% |
| June 30, 2025 | $157.88M | -20.0% | -8.2% |
| March 31, 2025 | $171.91M | -18.1% | -3.2% |
| December 31, 2024 | $177.54M | +104.9% | -7.3% |
| September 30, 2024 | $191.61M | — | -2.9% |
| June 30, 2024 | $197.36M | — | -6.0% |
| March 31, 2024 | $209.92M | — | +142.3% |
| December 31, 2023 | $86.63M | — | — |
- Alto Neuroscience, Inc. showed an increase of +4.0% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Alto Neuroscience, Inc.’s total assets has grown by 113.2% (from $86.63 million to $184.69 million).
- The most recent figure is from Alto Neuroscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: